Cyclic guanosine monophosphate and 10-year change in left ventricular mass: the Multi-Ethnic Study of Atherosclerosis (MESA)
Sign Up to like & getrecommendations! Published in 2021 at "Biomarkers"
DOI: 10.1080/1354750x.2021.1893811
Abstract: Abstract Purpose: Cyclic guanosine monophosphate (cGMP) is a second messenger for natriuretic peptide (NP) and nitric oxide pathways; its enhancement a target for heart failure and cardiovascular disease (CVD). We evaluated whether plasma cGMP was… read more here.
Keywords: guanosine monophosphate; change; cgmp; change left ... See more keywords